NIFTY, Intraday Tips, NSE, News, Mutual Fund, Commodity, Currency, World Market, Finance, Economic, BSE, Wealth, NPS, IPO, Portfolio, MCX, Investment Guru

02-08-2021 12:44 PM | Source: Angel Broking Ltd

Quote On GlaxoSmithKline Pharmaceutical Ltd 3QFY21 By Yash Gupta, Angel Broking

News By Tags | #5948 #607 #557 #6174

Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel

https://t.me/InvestmentGuruIndiacom

Download Telegram App before Joining the Channel

Below are Quote On GlaxoSmithKline Pharmaceutical Ltd 3QFY21 By Mr. Yash Gupta Equity Research Associate, Angel Broking Ltd

GSK Pharma reported numbers inline expectation, GlaxoSmithKline Pharmaceuticals Limited revenue from operations for Q3FY21 stood at ₹857 crores up by 10% YoY from ₹778 crores in Q3FY20. Profit before tax and exceptional items for the quarter up by 68% at ₹200.8 crores in Q3FY21 as compared to ₹119.5 crores in Q3FY20. Profit after tax for the quarter at ₹156.5 crores in Q3FY21 as compared to loss of ₹661 crores in Q3FY20. The losses in Q3FY20 are due to one time exceptional item of 753 crores.

GSK Pharma reported the numbers in line with expectations, the company has shown a steady growth in top line as well as on bottom line. Company margins are better then the expectations.

We have a Neutral outlook towards GSK Pharma.

Above views are of the author and not of the website kindly read disclaimer